Phase II study of VM 26 in extensively pretreated breast cancer

U. Tirelli, M. G. Trovo, G. Franchin

Research output: Contribution to journalArticle

Abstract

A significant activity of VM 26 in solid tumors has been established in brain tumors, bladder cancer, and neuroblastoma. Preliminary favorable results in breast cancer stimulated a phase II study at our institution to define the activity of VM 26 in patients with advanced, homogeneously pretreated breast cancer.

Original languageEnglish
Pages (from-to)451-452
Number of pages2
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume7
Issue number5
Publication statusPublished - 1984

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Phase II study of VM 26 in extensively pretreated breast cancer'. Together they form a unique fingerprint.

  • Cite this